The Precision Medicine and Functional Genomics (PMFG) 2022 conference, which will bring together academics, practitioners, decision-makers, and community members from around the world, is scheduled to take place from September 23 to September 26 at the St. Regis Doha.
Dr. Khalid Fakhro, chief research officer at Sidra Medicine, said in a statement that precision medicine “takes individual variations in genetics, pharmacogenomics, proteomics, microbiome, environmental, lifestyle factors, and others into account, allowing healthcare providers to improve the efficiency and effectiveness of disease prevention, diagnosis, and treatment.”
The sixth edition of the annual event, which will be preceded by a pre-symposium Biotech Forum tomorrow (September 22) at Sidra Medicine’s hospital auditorium, aims to “explore the latest developments and innovations in biomedical research and how they translate into precision medicine solutions”.
According to the organisers, the four-day in-person symposium has pre-and post-conference workshops, as well as a satellite half-day meeting focusing on two major themes: ‘How cellular, organoid, and animal models are being used to facilitate the discovery of basic disease mechanisms and potential cures;’ and ‘The development of advanced therapies to treat diseases.’
“Over the years, the PMFG series has grown significantly in topics and diversity with a wide range of speakers and a growing audience worldwide. As part of its National Vision 2030, Qatar is committed to building a knowledge-based economy in the biomedical and health sciences.
“Sidra Medicine supports this goal by actively engaging clinical and scientific expertise to establish a leading model for Precision Medicine in the region,” Dr Fakhro said.
He noted that the conference also aims to “discover how personalised medicine can move from vision to practice and to draft with us the roadmap for a personalised health data ecosystem”.
According to the conference’s organizers, attendees will get the chance to learn about coordinated efforts to advance precision medicine globally and, in particular, in the Middle Eastern area, as well as best practices for conducting productive precision medicine clinical trials. Learn about modeling of human tissues and diseases, how large-scale data resources, genome sequencing, and novel technologies are advancing precision medicine, and how advanced diagnostics and individualized treatments improve the quality of care for children with rare and chronic diseases (such as immune deficiency, hemoglobinopathy, cancer, etc.).
Leave a Reply